Lynx1 Capital Management LP bought $854K of Korro Bio (KRRO)

Executed Oct 22, disclosed Oct 26, 4 days later.

Value, as filed

$854K

77,299 sh across 3 lots

Executed

Oct 22

the trade date, as filed

Disclosed

Oct 26

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

not yet measured

Not yet measured: the 21-session window has not closed, or the prices around it are not on record.

The filer

LL Lynx1 Capital Management LP 10% owner profile →

Lynx1 Capital Management LP (10% owner) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (2 purchases, 0 sales), most often in Passage Bio, Inc. (PASG). Across 1 priced purchase filing, the average 21-session return was +1.5% from execution and -0.7% from disclosure (delay-adjusted; derived). The largest single filing was $854K of KRRO (77,299 sh across 3 lots, as filed), executed Oct 22.

The name

KRRO

Korro Bio, Inc. KRRO · Healthcare · 14 filings in 24 months ticker →

Healthcare · Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on edi…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→